Appointment of Chief Financial Officer
Sanofi India Ltd has informed BSE that Ms. Virginie Simone Jeanine Verrechia (Ms. Virginie Boucinha) who has been the Chief Financial Officer (CFO) from July 01, 2012 and Director of the Company from July 25, 2012 has stepped down as the CFO as she has taken up a senior position with the Sanofi Group in France.She continues to be a Non-Executive Director of the Company.... Change in Directorate
Sanofi India Ltd has informed BSE about the following changes which have taken place in the Board of Directors:1. Mr. J. M. Georges has resigned as Director of the Company with effect from the close of business hours on July 20, 2015 due to internal re-organisation in the Sanofi Group. Mr. Georges was Director from July 2010.2. Mr. M. G. Rao, who was Alternate to Mr. J. M. Georges, has consequently ceased to be Alternate Director.... Sanofi India Q2 net up 12% at Rs 64 cr
Drug firm Sanofi India today reported a 11.65 per cent rise in its standalone net profit at Rs 64.2 crore during second quarter ended June 30, 2015.The company, which follows January-Decembe... Limited Review for June 30, 2015
Sanofi India Ltd has submitted to BSE a Copy of the Limited Review Report for the period ended June 30, 2015. Sale of building owned by the Company in Andheri, Mumbai
Sanofi India Ltd has informed BSE that the Board of Directors of the Company has approved of the Company selling its commercial property, being land admeasuring 5493.1 sq. mts. bearing Survey No. 54-A Hissa No. 2 and C.T.S. No. 18 of Village Chakala, alongwith building known as Aventis House' standing thereon, situated at Sir Mathuradas Vasanji Road, Andheri (East) Mumbai - 400 093, for a consideration of Rs. 1110 million.... Board declares Interim Dividend
Sanofi India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on July 21, 2015, inter alia, has declared an Interim Dividend of Rs. 18 (Rupees Eighteen only) per Equity Share of Rs. 10 for the financial year ending December 31, 2015. The Interim Dividend will be paid on August 12, 2015. Announces Q2 results
Sanofi India Ltd has announced the following results for the quarter ended June 30, 2015 The Unaudited Standalone results for the Quarter ended June 30, 2015:The Company has posted a net profit of Rs. 642 million for the quarter ended June 30, 2015 as compared to Rs. 575 million for the quarter ended June 30, 2014. Total Income has increased from Rs. 5193 million for the quarter ended June 30, 2014 to Rs. 5596 million for the quarter ended June 30, 2015. Shareholding Pattern For June 30, 2015
Sanofi India Ltd has informed BSE about the Shareholding Pattern as on June 30, 2015. Fixes Record Date for Interim Dividend
Sanofi India Ltd has informed BSE that the Company has fixed July 30, 2015 as the Record Date for the purpose of Payment of Interim Dividend. Q2 results on July 21, 2015
Sanofi India Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on July 21, 2015 for :1. Approving the Unaudited Financial Results for the quarter and half year ended June 30, 2015 (Q2); and2. Considering the question of declaring an Interim Dividend for the current financial year ending on December 31, 2015.